Fundraising Fox

Biotech Startups

9,990 companies tagged Biotech, with their investors and founders.

COURAGE THERAPEUTICS, INC.

0 investors

CraniUS

0 investors

Creative BioTherapeutics

0 investors

Creative Medical Technology Holdings

Creative Medical Technology Holdings (CELZ) is a biotechnology company developing regenerative medicine and immunotherapy platforms for conditions in immunology, endocrinology, urogynecology, and orthopedics. Its technologies include autologous immunotherapy (ImmCelz), an allogenic cell platform (AlloStem), a cellular reprogramming platform (iPSCELZ), and rapid autologous therapy programs (StemSpine, OvaStem, CaverStem).

0 investors

Credence MedSystems

Credence MedSystems develops drug delivery and medical device technologies for pharmaceutical manufacturers and healthcare providers. The company is led by executives with extensive backgrounds in medical technology commercialization and surgical device innovation.

0 investors

Crescel

0 investors

Crimson BioPharm

0 investors

Cristcot

0 investors

Cross Vascular

0 investors

Crossfire Medical

0 investors

CRS Bio

0 investors

Cryo Venture Debt

0 investors

CryoConcepts

0 investors

Cryolife

CryoLife develops technologies for aortic treatment, positioning itself in the cardiovascular medical device field.

0 investors

Cryoport

0 investors

CryptoMedix

CryptoMedix Inc. is a pre-clinical biotech developing first-in-class therapeutic antibodies (CMX-101 and CMX-102) targeting the tumor microenvironment for immuno-oncology, promoting cytotoxic T-cell activity and interacting with immune checkpoints such as PD(L)1 and LAG-3. Its CMX-102 antibody is also positioned for use as antibody-drug conjugates and radionuclide conjugates targeting tumor cells.

0 investors

CTD Holdings

0 investors

CTI Science

0 investors

CTRL Therapeutics USA

0 investors

Cue Biopharma

Cue Biopharma is a precision immunotherapy company developing engineered therapies targeting allergic and autoimmune diseases. The company's pipeline includes CUE-221 for IgE-mediated allergic disease and CUE-401 advancing from its proprietary Immuno-STAT platform for autoimmune conditions.

0 investors

Cullinan Mica

0 investors

Cupron

0 investors

Cupron Performance Additives

0 investors

Curative Biotechnology

0 investors

Other sectors & tags